Baylor Genetics employs advanced genetic testing technologies to provide comprehensive diagnostic solutions. Their offerings include Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES), which are designed to analyze the entire genome or the protein-coding regions, respectively. These technologies enable the identification of genetic variants that may contribute to various health conditions, with the potential to reclassify and resolve 10-15% of qualified variants, thereby delivering quicker and more actionable diagnostic answers. Additionally, Baylor Genetics utilizes Chromosomal Microarray analysis and Mitochondrial Testing, which further enhance their ability to detect genetic abnormalities and inherited conditions.

The company also emphasizes rapid testing capabilities, allowing for timely results that are crucial in clinical settings such as reproductive health, pediatrics, and oncology. Their genetic testing services are supported by a team of experts, including PhDs and genetic counselors, who collaborate with the Baylor College of Medicine to ensure high-quality analysis and interpretation of genetic data. This integration of cutting-edge technologies and expert knowledge positions Baylor Genetics as a leader in the field of genetic testing, catering to the needs of healthcare providers and their patients.

United States

Baylor Genetics offers a full spectrum of cost-effective, genetics testing and provides clinically relevant solutions. They offer whole exome sequencing, prenatal diagnostics, cytogenetics, molecular diagnostics, oncology, chromosomal microarray analysis, and over 30 enzyme assays. Along with these tests come interpretation services.

Baylor Genetics

Company Details